Darbepoetin Alfa

Alternative Names: Aranesp

Darbepoetin alfa is a long-acting form of erythropoietin used to treat anemia, mainly in patients with chronic kidney disease or those receiving chemotherapy. Like epoetin alfa, it stimulates the bone marrow to make more red blood cells, but it lasts longer in the body, so injections are needed less often. It can reduce the need for blood transfusions and improve symptoms like fatigue and weakness. However, it carries risks such as high blood pressure, blood clots, stroke, or heart problems

Treatment Type: Prescription Medication

Treatment Class: Erythropoiesis-stimulating agent

Treatment Modality: Injection, Intravenous (IV)

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Darbepoetin Alfa appears to be an effective treatment for anemia, particularly in patients with chronic kidney disease or undergoing chemotherapy. It works by stimulating red blood cell production in the bone marrow and has the advantage of requiring less frequent dosing compared to similar medications, which can improve patient convenience and potentially reduce blood transfusion needs.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
3.0
1 = Very Expensive 5 = Very Affordable

3.0

Moderate Cost
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Darbepoetin Alfa appears to be an effective treatment for anemia, particularly in patients with chronic kidney disease or undergoing chemotherapy. It works by stimulating red blood cell production in the bone marrow and has the advantage of requiring less frequent dosing compared to similar medications, which can improve patient convenience and potentially reduce blood transfusion needs.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
4 months ago
Darbepoetin alfa is used for anemia because it stimulates the bone marrow to produce more red blood cells, similar to epoetin alfa, but with a longer half-life. This means it can be given less frequently, which is more convenient for patients. It is commonly used in anemia from chronic kidney disease or chemotherapy to reduce the need for blood transfusions.
#ModerateCost #SlowRelief #MildEffect #Second-line #Maintenance